000 01619 a2200505 4500
005 20250518040919.0
264 0 _c20190802
008 201908s 0 0 eng d
022 _a1365-2184
024 7 _a10.1111/cpr.12636
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Xu
245 0 0 _aGolgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.
_h[electronic resource]
260 _bCell proliferation
_cJul 2019
300 _ae12636 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
_xdrug effects
650 0 4 _aCell Proliferation
_xphysiology
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aGefitinib
_xpharmacology
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMembrane Proteins
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aWang, Zhaohao
700 1 _aZhang, Yu
700 1 _aWang, Yan
700 1 _aZhang, Hao
700 1 _aXie, Shao
700 1 _aXie, Peng
700 1 _aYu, Rutong
700 1 _aZhou, Xiuping
773 0 _tCell proliferation
_gvol. 52
_gno. 4
_gp. e12636
856 4 0 _uhttps://doi.org/10.1111/cpr.12636
_zAvailable from publisher's website
999 _c29695399
_d29695399